EB Therapeutics (EBT) is the virtual biotech arm of Cure EB, a subsidiary not-for-profit organisation, which is 100% owned by the charity. EBT seeks to develop products targeting our core mission, with any profits put straight back into the charity.
We believe that effective treatments and a cure for EB are possible. EBT aims to further develop technologies supported by Cure EB – aiding transition from research to market – accelerating the pace at which effective treatments can be made available to the patients that need them.
By utilising philanthropy, EBT intends to keep the cost of new treatments as low as possible, making treatments viable for payers and accessible to patients.
